mibefradil has been researched along with ethosuximide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Adarayan, ED; Ballard, JE; Barrow, JC; Bock, MG; Bunting, PB; Connolly, TM; DiLella, AG; Doran, SM; Fox, SV; Graufelds, VK; Hartman, GD; Koblan, KS; Kraus, RL; Kuo, Y; Lindsley, CW; Magee, MM; Marino, MJ; Nuss, CE; Prueksaritanont, T; Renger, JJ; Reynolds, IJ; Rittle, KE; Schlegel, KA; Shipe, WD; Shu, Y; Tang, C; Uebele, VN; Vargas, HM; Woltmann, RF; Yang, FV; Yang, ZQ; Zrada, MM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Du Nguyen, H; Horaguchi, Y; Kasanami, Y; Kawabata, A; Kitamura, S; Nishikawa, H; Okada, T; Sekiguchi, F; Toyooka, N; Tsubota, M; Yamaoka, S; Yoshida, S | 1 |
| Antepohl, W; Haaf, O; Herzig, S; Huber, I; Matthes, J; Striessnig, J | 1 |
| Dogrul, A; Gardell, LR; Lai, J; Ossipov, MH; Porreca, F; Tulunay, FC | 1 |
| Barton, ME; Eberle, EL; Shannon, HE | 1 |
| Castro-Alamancos, MA; Rigas, P; Tawara-Hirata, Y | 1 |
| Chen, CC; Cheng, JK; Chiou, LC; Lin, CS; Yang, JR | 1 |
| Broicher, T; Budde, T; Kanyshkova, T; Meuth, P; Meuth, SG; Munsch, T; Pape, HC; Seidenbecher, T | 1 |
| Chang, YF; Chen, YL; Cheng, JK; Hung, YC; Lin, CS; Shiue, SJ; Tsaur, ML; Wang, SW; Wang, TY; Wang, YC | 1 |
| Aceto, R; Bootman, MD; Chandler, S; Crea, F; Matheou, C; Mather, R; Pucci, P; Rietdorf, K; Rigas, SH; Silvestri, R; Venalainen, E; Wang, Y | 1 |
13 other study(ies) available for mibefradil and ethosuximide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Cardiovascular System; Drug Evaluation, Preclinical; Humans; Molecular Structure; Piperidines; Rats; Structure-Activity Relationship | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers.
Topics: Action Potentials; Analgesics; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; Drug Design; Flavonoids; HEK293 Cells; Humans; Inhibitory Concentration 50; Male; Mice; Neuralgia; Patch-Clamp Techniques; Structure-Activity Relationship | 2018 |
Pharmacodynamic interaction between mibefradil and other calcium channel blockers.
Topics: Amlodipine; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Cell Membrane; Dihydropyridines; Drug Interactions; Ethosuximide; Female; Gallopamil; Humans; In Vitro Techniques; Isradipine; Male; Mibefradil; Myocardial Contraction; Perfusion; Radioligand Assay; Rats; Rats, Wistar; Ventricular Pressure | 2000 |
Reversal of experimental neuropathic pain by T-type calcium channel blockers.
Topics: Administration, Topical; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Dose-Response Relationship, Drug; Ethosuximide; Foot; Hot Temperature; Injections, Intraperitoneal; Injections, Spinal; Ligation; Male; Mibefradil; Neuralgia; Rats; Rats, Sprague-Dawley; Spinal Nerves; Touch; Wounds, Nonpenetrating | 2003 |
The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil.
Topics: Animals; Anticonvulsants; Behavior, Animal; Calcium Channel Blockers; Calcium Channels, T-Type; Dose-Response Relationship, Drug; Ethosuximide; Hyperalgesia; Male; Mibefradil; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Time Factors; Trimethadione | 2005 |
Resonance (approximately 10 Hz) of excitatory networks in motor cortex: effects of voltage-dependent ion channel blockers.
Topics: Anesthetics, Local; Animals; Calcium Channel Blockers; Electrophysiology; Ethosuximide; Evoked Potentials; Excitatory Amino Acid Antagonists; In Vitro Techniques; Ion Channels; Magnesium; Mibefradil; Mice; Motor Cortex; Neocortex; Phenytoin; Potassium Channel Blockers; Potassium Channels; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Riluzole; Sodium Channel Blockers; Tetrodotoxin | 2007 |
Effects of intrathecal injection of T-type calcium channel blockers in the rat formalin test.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; Dose-Response Relationship, Drug; Ethosuximide; Formaldehyde; Hindlimb; Injections, Spinal; Long-Term Potentiation; Male; Mibefradil; Neural Inhibition; Neuronal Plasticity; Nickel; Nociceptors; Pain Threshold; Rats; Rats, Sprague-Dawley; Spinal Cord | 2007 |
T-current related effects of antiepileptic drugs and a Ca2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy.
Topics: Animals; Animals, Newborn; Anticonvulsants; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Electroencephalography; Epilepsy, Absence; Ethosuximide; Interneurons; Membrane Potentials; Mibefradil; Patch-Clamp Techniques; Rats; Rats, Inbred ACI; Thalamus | 2007 |
Chronic intrathecal infusion of mibefradil, ethosuximide and nickel attenuates nerve ligation-induced pain in rats.
Topics: Animals; Anticonvulsants; Calcium Channel Blockers; Disease Models, Animal; Ethosuximide; Ligation; Male; Mibefradil; Neuralgia; Nickel; Rats; Rats, Sprague-Dawley | 2015 |
T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cells.
Topics: Calcium Channel Blockers; Calcium Channels, T-Type; Cell Line, Tumor; Cell Proliferation; Ethosuximide; Humans; Male; Mibefradil; Molecular Targeted Therapy; PC-3 Cells; Prognosis; Prostatic Neoplasms; Receptors, Androgen; Up-Regulation | 2019 |